Skip to content
Dabour HubLEARN · PRACTICE · EXPLORESign inStudent

8.2.6Topic 8 · Grey Matter

Imbalances in Brain Chemicals Leading to Diseases — Edexcel A Level Biology A (SNAB) 9BI0 Revision Notes & Topical Questions

5 min read 9 parts Lesson 17 of 22 1 quiz

🩺
100% Curriculum Specification Match Lesson Doctor Verified
The only platform with 100% curriculum specification match and verified interactive question banks.
0%read
Lesson summary

8.2.6 Imbalances in Brain Chemicals Leading to Diseases — Edexcel A Level Biology A (SNAB) 9BI0 notes: Explain how changes in the amount or action of neurotransmitters such as dopamine and serotonin are linked to Parkinson's disease and depression.Neurones communicate across syna…

  • Exam-style question 1
  • Exam-style question 2
  • Exam-style question 3
  • Blood-brain barrier
  • If any part of this changes, the brain's chemistry is unbalanced and behaviour or movement can be affected
  • It has been linked to low levels of serotonin (and related transmitters) at synapses in certain brain areas

Section 1 of 9Neurotransmitters and their balance

Neurones communicate across synapses by releasing neurotransmitters, which bind to receptors on the postsynaptic membrane.

Neurotransmitters and their balance
The effect depends on the amount released, the number and sensitivity of receptors and how quickly the transmitter is removed (by enzymes or by reuptake into the presynaptic neurone).
If any part of this changes, the brain's chemistry is unbalanced and behaviour or movement can be affected.
Some diseases are strongly linked to particular neurotransmitters, although the whole picture is complex and not fully understood.

Section 2 of 9Parkinson's disease and dopamine

Parkinson's disease is a progressive condition in which neurones in a part of the midbrain, the substantia nigra, die. These neurones release dopamine in the basal ganglia, which help control voluntary movement. With less dopamine, signals that start and smooth movement are reduced. Symptoms include tremor, muscle rigidity, slow movement and difficulty starting to move.

Treatment commonly uses L-dopa, a precursor of dopamine that crosses the blood-brain barrier and is converted to dopamine in the brain. Dopamine itself cannot cross the barrier. Other drugs act as dopamine agonists or inhibit the enzyme that breaks down dopamine. They relieve symptoms but do not cure the disease, and over time they become less effective.

Section 3 of 9Depression and serotonin

Depression is a mood disorder with persistent low mood and loss of interest.

Serotonin
It has been linked to low levels of serotonin (and related transmitters) at synapses in certain brain areas.
Many antidepressants, called SSRIs (selective serotonin reuptake inhibitors), block the transporter proteins that return serotonin to the presynaptic neurone.
Serotonin therefore remains longer in the synaptic cleft and keeps stimulating the postsynaptic receptors.

The link is not simple

  • SSRIs raise serotonin quickly but mood improves only after weeks, and not all patients respond.
  • Genes, environment and life events also influence depression, so serotonin level is a risk factor, not the single cause.

Section 4 of 9Other examples and interpretation

Other examples and interpretation
Schizophrenia has been linked to overactivity of dopamine pathways; many antipsychotics block dopamine receptors.
Addiction involves dopamine in reward pathways (see the next lesson).

When interpreting data on transmitter levels, look for correlation with symptoms, consider sample size, and remember that a correlation does not prove a causal link. Measurements are often made after death or by imaging, which have their own limitations.

Section 5 of 9Links

This topic links to synaptic transmission, the effect of drugs on synapses and personalised medicine, where a patient's genes affect the response to a drug.

Section 6 of 9Alzheimer's disease, schizophrenia and the limits of the chemical explanation

Other brain diseases also show chemical changes.

Alzheimer's disease, schizophrenia and the limits of the chemical explanation
In Alzheimer's disease, neurones in the cortex and hippocampus degenerate and the level of acetylcholine falls; drugs that inhibit acetylcholinesterase keep acetylcholine in the cleft for longer and can slow the loss of memory for a time,
  • although they do not stop the disease.
Abnormal protein deposits, including plaques of amyloid, are also found, and these are a focus for new treatments.

In schizophrenia, overactivity of dopamine pathways is thought to contribute to hallucinations and delusions.

Alzheimer's disease, schizophrenia and the limits of the chemical explanation
Evidence includes the fact that amphetamines,
  • which raise dopamine, can produce similar symptoms,
  • while antipsychotic drugs that block dopamine receptors reduce them.
However, the drugs do not work for all patients and some symptoms, such as lack of motivation, are not helped,
  • so other transmitters, including glutamate, are probably involved.

These examples teach an important point about scientific reasoning.

1
A chemical imbalance found in patients may be the cause of a disease, or it may be a result of the disease or its treatment.
2
Evidence that supports a causal link includes a plausible mechanism, results of drugs that change the transmitter and consistent findings in different studies.
3
Be careful in an evaluation to say "linked to" rather than "caused by",
  • and mention that genetics, environment and development influence all these diseases.
4
Treatment should therefore combine drugs with other support, such as therapy and social care.

Nerve cells in the brain can also be affected by too much transmitter. Excess glutamate can overstimulate and damage neurones, which is thought to contribute to damage after a stroke. This shows that balance, rather than simply more or less, is what matters in a healthy brain.

Section 7 of 9Exam-style questions

  1. Explain how a lack of dopamine causes the symptoms of Parkinson's disease. [3]3 marks

  2. Explain why L-dopa is given instead of dopamine. [2]2 marks

  3. Describe how an SSRI works. [3]3 marks

Section 8 of 9Key terms

TermMeaning
DopamineNeurotransmitter involved in movement and reward
SerotoninNeurotransmitter involved in mood and sleep
SSRIDrug that blocks the reuptake of serotonin
L-dopaPrecursor of dopamine used to treat Parkinson's disease
ReuptakeReturn of neurotransmitter from the cleft into the presynaptic neurone
Blood-brain barrierSelective barrier between blood and brain tissue

Section 9 of 9Exam technique

1
Saying the drugs cure Parkinson's disease; they relieve symptoms only.
2
Saying depression is caused only by low serotonin.
3
Confusing SSRIs (block reuptake) with drugs that increase release.
4
Writing that dopamine is given as a drug for Parkinson's; it cannot cross the barrier.

Last updated: